Biologic Drugs With Established Pharmaceutical Class: Type I Interferon Receptor Antagonist
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Type I Interferon Receptor Antagonist
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca Ab | SAPHNELO | anifrolumab-fnia | Injection | 761123 | 2021-07-30 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |